Tang S, Lai K N, Chan T M, Lan H Y, Ho S K, Sacks S H
Department of Nephrology and Transplantation, Guy's, King's College and St Thomas' Hospitals' Medical School, King's College, London, UK.
Am J Kidney Dis. 2001 Jan;37(1):94-103. doi: 10.1053/ajkd.2001.20593.
Complement is increasingly implicated in the pathogenesis of progressive renal disease resulting from persistent proteinuria. We have previously shown that apical serum proteins stimulate C3 in cultured human proximal tubular epithelial cells (PTECs), and that the stimulant is a nonalbumin compound of 30 to 100 kd. We postulated in this study that transferrin and apotransferrin, also important components of proteinuric urine in this molecular-weight range, might be the culprit. Human PTECs were obtained by differential sieving of renal cortical tissue from the normal pole of tumor nephrectomy specimens and characterized to be predominantly of proximal tubular origin. Complement C3 messenger RNA (mRNA) expression was analyzed in confluent growth-arrested PTEC monolayers in media containing different concentrations (2.5 to 20 mg/mL) of transferrin by reverse transcription and polymerase chain reaction. Pure human albumin was used as a control protein. C3 protein secretion was detected and quantified by a sandwich enzyme-linked immunosorbent assay on cell culture supernatants after distinct time points. Transferrin enhanced the rate of C3 secretion in a dose-dependent manner, reaching maximal stimulation at doses of 10 mg/mL. Selected experiments using the Transwell technique showed that C3 release was predominantly apical in the resting state. The addition of 10 mg/mL of transferrin apically but not basolaterally stimulated both apical and basolateral C3 secretion and increased the basolateral-apical ratio of C3 secretion from 0.45 +/- 0.16 to 0.93 +/- 0.24 (P: < 0.02). Constitutive C3 mRNA expression was upregulated by transferrin in a time- and dose-dependent fashion, reaching a peak after 24 hours. A similar degree of C3 upregulation was reproduced when iron-poor transferrin, apotransferrin, was used instead. These results indicate that C3 synthesis in PTECs is upregulated by transferrin, for which protein rather than iron moiety may account for the observed effects. These findings provide evidence linking proteinuria with overexpression of tubular complement.
补体越来越多地与持续性蛋白尿导致的进行性肾病发病机制相关。我们之前已经表明,顶端血清蛋白可刺激培养的人近端肾小管上皮细胞(PTECs)中的C3,并且刺激物是一种30至100kd的非白蛋白化合物。我们在本研究中推测,转铁蛋白和脱铁转铁蛋白,也是该分子量范围内蛋白尿的重要成分,可能是罪魁祸首。通过对肿瘤肾切除标本正常极的肾皮质组织进行差异筛分获得人PTECs,并鉴定其主要来源于近端肾小管。通过逆转录和聚合酶链反应,在含有不同浓度(2.5至20mg/mL)转铁蛋白的培养基中,对汇合生长停滞的PTEC单层中的补体C3信使核糖核酸(mRNA)表达进行分析。纯人白蛋白用作对照蛋白。在不同时间点后,通过夹心酶联免疫吸附测定法检测并定量细胞培养上清液中的C3蛋白分泌。转铁蛋白以剂量依赖性方式提高C3分泌速率,在10mg/mL剂量时达到最大刺激。使用Transwell技术进行的选定实验表明,在静息状态下C3释放主要是顶端性的。顶端加入10mg/mL转铁蛋白而非基底外侧加入转铁蛋白可刺激顶端和基底外侧C3分泌,并使C3分泌的基底外侧与顶端比率从0.45±0.16增加到0.93±0.24(P:<0.02)。组成性C3 mRNA表达以时间和剂量依赖性方式被转铁蛋白上调,在24小时后达到峰值。当使用缺铁转铁蛋白即脱铁转铁蛋白时,也出现了类似程度的C3上调。这些结果表明,PTECs中的C3合成被转铁蛋白上调,观察到的效应可能是由蛋白质而非铁部分引起的。这些发现提供了将蛋白尿与肾小管补体过表达联系起来的证据。